Get the Stockscreener App
0.00
100.00%
-24.41
After Hours:
24.85
24.85
+
Newamsterdam Pharma Company N V stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, develops oral and non-statin medicines for patients at high risk of cardiovascular disease. Its lead product candidate is obicetrapib, a next generation, oral, and low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in four ongoing Phase 3 and Phase 2b clinical trials as both a monotherapy and a combination therapy with ezetimibe for lowering LDL-C and preventing major adverse cardiovascular events (MACE). NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
See More
Previous Close:
$24.41
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$24.41
52-Week Range:
$0.00
$29.55
Newamsterdam Pharma Company N V Stock (NAMSW) Company Profile
Name
Newamsterdam Pharma Company N V
Sector
Industry
Phone
31 35 206 2971
Address
Gooimeer 2-35, Naarden
Compare NAMSW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAMSW
Newamsterdam Pharma Company N V
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
417.21 | 108.30B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
652.91 | 69.37B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.59 | 62.38B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
821.97 | 51.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
166.95 | 34.94B | 398.11M | -1.03B | -868.57M | -5.7032 |
Newamsterdam Pharma Company N V Stock (NAMSW) Latest News
Can NewAmsterdam Pharma Company N.V. (KH6) stock surprise markets with earnings2025 Top Decliners & Proven Capital Preservation Methods - newser.com
Is NewAmsterdam Pharma Company N.V. stock poised for growthQuarterly Portfolio Report & Verified High Yield Trade Plans - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock reacts to oil pricesBreakout Watch & Safe Capital Investment Plans - newser.com
Volatility clustering patterns for NewAmsterdam Pharma Company N.V.July 2025 Trends & Precise Swing Trade Entry Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a top pick in earnings seasonPrice Action & Growth Focused Investment Plans - newser.com
Pattern recognition hints at NewAmsterdam Pharma Company N.V. upsideTrade Ideas & Fast Exit and Entry Strategy Plans - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock maintain momentum in 2025 - newser.com
Using data models to predict NewAmsterdam Pharma Company N.V. Equity Warrant stock movement2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock prepared for digital transition - newser.com
How to escape a deep drawdown in NewAmsterdam Pharma Company N.V.2025 Top Decliners & AI Forecasted Entry and Exit Points - newser.com
Can volume confirm reversal in NewAmsterdam Pharma Company N.V. Equity WarrantWeekly Profit Summary & AI Driven Stock Price Forecasts - newser.com
Why NewAmsterdam Pharma Company N.V. stock is seen as undervaluedJuly 2025 Earnings & Fast Entry and Exit Trade Plans - newser.com
Why retail investors pile into NewAmsterdam Pharma Company N.V. Equity Warrant stockPortfolio Performance Report & Daily Volume Surge Signals - newser.com
What candlestick patterns are forming on NewAmsterdam Pharma Company N.V. Equity Warrant2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Patterns & Fast Moving Trade Plans - newser.com
Using economic indicators to assess NewAmsterdam Pharma Company N.V. Equity Warrant potential2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com
Is NewAmsterdam Pharma Company N.V. stock positioned well for digital economyJuly 2025 Institutional & Stepwise Trade Execution Plans - Fundação Cultural do Pará
Will NewAmsterdam Pharma Company N.V. stock outperform international peers2025 Technical Overview & Technical Entry and Exit Alerts - Fundação Cultural do Pará
Will NewAmsterdam Pharma Company N.V. stock maintain dividend yield2025 Year in Review & Safe Investment Capital Preservation Plans - Fundação Cultural do Pará
Advanced analytics toolkit walkthrough for NewAmsterdam Pharma Company N.V. Equity Warrant - newser.com
Visual analytics tools that track NewAmsterdam Pharma Company N.V. Equity Warrant performanceWeekly Profit Report & Accurate Buy Signal Notifications - newser.com
What does recent volatility data suggest for NewAmsterdam Pharma Company N.V. Equity WarrantAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Technical analysis overview for NewAmsterdam Pharma Company N.V. Equity Warrant stockTrade Volume Summary & Safe Entry Zone Tips - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investors2025 Market Sentiment & Weekly Watchlist for Hot Stocks - newser.com
Will NewAmsterdam Pharma Company N.V. (KH6) stock beat Nasdaq index returns2025 Short Interest & Intraday High Probability Setup Alerts - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock benefit from commodity pricesMarket Performance Recap & Advanced Technical Signal Analysis - newser.com
Published on: 2025-10-28 04:38:45 - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock compares to market leadersExit Point & Daily Technical Forecast Reports - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock bottoming outDollar Strength & Verified Chart Pattern Trade Signals - newser.com
How to build a custom watchlist for NewAmsterdam Pharma Company N.V.Weekly Trade Review & Entry Point Confirmation Signals - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock keep outperforming rivalsPortfolio Value Summary & Smart Money Movement Tracker - Fundação Cultural do Pará
How hedge fund analytics apply to NewAmsterdam Pharma Company N.V. stock2025 Performance Recap & High Accuracy Trade Alerts - newser.com
Key resistance and support levels for NewAmsterdam Pharma Company N.V.Quarterly Trade Review & Safe Capital Investment Plans - newser.com
Risk adjusted return profile for NewAmsterdam Pharma Company N.V. Equity Warrant analyzedBear Alert & Daily Stock Trend Watchlist - newser.com
Is it too late to sell NewAmsterdam Pharma Company N.V. Equity Warrant2025 Buyback Activity & Precise Buy Zone Tips - newser.com
Can NewAmsterdam Pharma Company N.V. stock resist sector downturnsChart Signals & Precise Entry and Exit Recommendations - newser.com
How institutional buying supports NewAmsterdam Pharma Company N.V. Equity Warrant stock - Fundação Cultural do Pará
NewAmsterdam Pharma Company N.V. recovery potential after sell offMarket Weekly Review & Momentum Based Trading Ideas - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock trading at a premium valuationJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock benefit from upcoming earnings reports2025 Historical Comparison & Weekly Watchlist for Hot Stocks - newser.com
Tools to assess NewAmsterdam Pharma Company N.V.’s risk profileGlobal Markets & Expert Curated Trade Setup Alerts - newser.com
Newamsterdam Pharma Company N V Stock (NAMSW) Financials Data
There is no financial data for Newamsterdam Pharma Company N V (NAMSW). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.71%
1.60%
Cap:
|
Volume (24h):